MDxHealth SA Net Income 2018-2025 | MDXH

MDxHealth SA net income from 2018 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
MDxHealth SA Annual Net Income
(Millions of US $)
2024 $-38
2023 $-43
2022 $-44
2021 $-29
2020 $-29
2019 $-43
2018 $-32
2017 $-12
2016 $-13
MDxHealth SA Quarterly Net Income
(Millions of US $)
2025-03-31 $-9
2024-12-31 $-7
2024-09-30 $-11
2024-06-30 $-12
2024-03-31 $-9
2023-12-31 $-11
2023-09-30 $-10
2023-06-30 $-11
2023-03-31 $-12
2022-12-31
2022-09-30 $-14
2022-06-30
2022-03-31 $-8
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.114B $0.090B
MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.605B 59.29
Hims & Hers Health (HIMS) United States $11.194B 116.30
Doximity (DOCS) United States $11.153B 51.63
Tempus AI (TEM) United States $10.574B 0.00
IRhythm Technologies (IRTC) United States $4.258B 0.00
Inspire Medical Systems (INSP) United States $3.817B 59.65
Hinge Health (HNGE) United States $3.642B 0.00
Privia Health (PRVA) United States $2.447B 167.25
Schrodinger (SDGR) United States $1.671B 0.00
Clover Health Investments (CLOV) United States $1.639B 0.00
10x Genomics (TXG) United States $1.600B 0.00
Phreesia (PHR) United States $1.595B 0.00
Enovis (ENOV) United States $1.556B 8.68
Azenta (AZTA) United States $1.507B 70.04
Omnicell (OMCL) United States $1.324B 23.35
Evolent Health (EVH) United States $1.147B 97.70
Claritev (CTEV) United States $0.702B 0.00
Fulgent Genetics (FLGT) United States $0.567B 0.00
Standard BioTools (LAB) United States $0.517B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Butterfly Network (BFLY) United States $0.467B 0.00
Talkspace (TALK) United States $0.435B 130.00
TruBridge (TBRG) United States $0.336B 745.67
Outset Medical (OM) United States $0.336B 0.00
Health Catalyst (HCAT) United States $0.274B 0.00
Nyxoah SA (NYXH) Belgium $0.266B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.229B 0.00
CapsoVision (CV) United States $0.204B 0.00
Zepp Health (ZEPP) Netherlands $0.173B 0.00
KORU Medical Systems (KRMD) United States $0.158B 0.00
Pulmonx (LUNG) United States $0.130B 0.00
American Well (AMWL) United States $0.128B 0.00
EUDA Health Holdings (EUDA) Singapore $0.112B 0.00
CareCloud (CCLD) United States $0.102B 3.89
Insight Molecular Diagnostics (IMDX) United States $0.081B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.078B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00